Joint Statement: Blood Community Reiterates the Safety of America’s Blood Supply for Patients

January 27, 2023

The following statement has been issued by AABB, America’s Blood Centers and the American Red Cross regarding misinformation concerning COVID-19 vaccines and blood donations: Amid ongoing misinformation about COVID-19 vaccinations…

America’s Blood Centers Releases Recruitment Video to Help Attract a Diverse Pool of Jobseekers at Blood Centers Nationwide

November 8, 2022

New resource is designed to help blood centers in the face of workplace shortages impacting industries across the country **View the video here** Washington, DC – America’s Blood Centers (ABC),…

As Hurricane Ian Makes Landfall, Individuals in Unaffected Areas Urged to Donate Blood

September 28, 2022

As Hurricane Ian reaches Florida and moves throughout the Southeast with dangerous storm surges, winds and flooding, the AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism strongly…

Phase I In-human Trial of Potential RBC Substitute Reported

September 9, 2022

A research letter authored by investigators in Japan has been published in Blood Advances reporting on the first-in-human phase I clinical trial of hemoglobin-vesicles (HbVs) developed as a transfusion alternative.…

Health Canada Authorizes Héma-Québec Submission for Move to Individual Risk-based Donor Screening Criteria

September 9, 2022

Health Canada, the country’s regulatory authority, announced this week that it has “authorized a submission from Héma-Québec to implement a more inclusive approach to blood donor screening.” According to a…

FDA Publishes Communication for HCT/P Establishments Regarding Monkeypox Virus

September 2, 2022

The U.S. Food and Drug Administration (FDA) issued a communication on August 29th titled “Important Information for Human Cell, Tissue, and Cellular and Tissue-based Product (HCT/P) Establishments Regarding Monkeypox Virus…

America’s Blood Centers, Allies Mark Sickle Cell Awareness Month with a Call for Diverse Donors

August 31, 2022

Increased diversity among blood donors critical to treatment of Sickle Cell patients Washington, DC – America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60…

CMS Extends Comment Period for CLIA Fees Proposed Rule

August 26, 2022

The Centers for Medicare and Medicaid Services (CMS) extended the comment period to September 26th for a proposed rule titled “Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel,…

Research from 3 Member Blood Centers Shows SARS-CoV-2 RNA from Pre-Symptomatic Donor Plasma Not Infectious in Models

August 26, 2022

Although there has been no evidence of transfusion-transmitted SARS-CoV-2 resulting in COVID-19 and the U.S. blood supply is extraordinarily safe, a study published in The Journal of Clinical Investigation that…

Gene Therapy Approved by FDA for Beta-Thalassemia Patients Requiring Blood Transfusions

August 19, 2022

The U.S. Food and Drug Administration (FDA) approved the first “cell-based gene therapy treatment” for use in individuals with beta-thalassemia who require regular blood cell transfusions. “Today’s approval is an…

News

Joint Statement: Blood Community Reiterates the Safety of America’s Blood Supply for Patients

America’s Blood Centers Releases Recruitment Video to Help Attract a Diverse Pool of Jobseekers at Blood Centers Nationwide

As Hurricane Ian Makes Landfall, Individuals in Unaffected Areas Urged to Donate Blood

America’s Blood Centers, Allies Mark Sickle Cell Awareness Month with a Call for Diverse Donors

Search

Categories

Contact